ViraTherapeutics GmbH
4Patents
4Active
4Granted
42Portfolio score
Filing activity: Oct 8, 2009 → Jan 24, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10265357B2 | Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors | Chemistry; Metallurgy | 3 | Active |
| US9650649B2 | LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors | Chemistry; Metallurgy | 1 | Active |
| US9963718B2 | LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors | Chemistry; Metallurgy | 0 | Active |
| US11707495B2 | Recombinant rhabdovirus encoding for CCL21 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.